Daily News Podcast

Lorcaserin shows cardiovascular safety


 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Mobile contraception app gets FDA approval
MDedge ObGyn
Variation doesn’t mean quality when it comes to diet
MDedge ObGyn
Breast arterial calcification, low bone mass predict CAD in women
MDedge ObGyn
Medicare Advantage pushback
MDedge ObGyn
Cardiovascular risk management supported for type 2 diabetes
MDedge ObGyn
An epidemic of non-alcoholic fatty liver disease
MDedge ObGyn
Sleepio app tied to reducing insomnia, depression
MDedge ObGyn
5 digital HIPAA myths
MDedge ObGyn
Screen for cervical cancer based on age, risk
MDedge ObGyn
Is it time for PCPs to take over chronic HCV?
MDedge ObGyn